Sean Lilienfeld
Sean Lilienfeld publishes mostly in Pharmacology, Organic Chemistry and Neurology, on topics such as Chemical synthesis and alkaloids, Cholinesterase and Neurodegenerative Diseases and Dementia and Cognitive Impairment Research.
- World rank
- #2,017,089 of 7,710,434 ranked researchers
- Rank in United States
- #611,898 of 1,627,098
- Works
- 36
- Citations
- 3.6k
- Citations per work
- 99.5
What does Sean Lilienfeld research?
Sean Lilienfeld's work is mostly in Medicine (31%), Neuroscience (12%), Chemistry (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1234.0%
- Health Sciences1130.8%
- Medicine1130.8%
- Life Sciences823.1%
- Physical Sciences412.1%
- Chemistry412.1%
- 1Pharmacology14% of their works
- 2Organic Chemistry12% of their works
- 3Neurology12% of their works
- 4Molecular Biology11% of their works
- 5Psychiatry and Mental health11% of their works
- 6Surgery6% of their works
Research topics
- Chemical synthesis and alkaloids
- Cholinesterase and Neurodegenerative Diseases
- Dementia and Cognitive Impairment Research
- Nicotinic Acetylcholine Receptors Study
- Neurological Disorders and Treatments
- Neurological Disease Mechanisms and Treatments
- Cerebrospinal fluid and hydrocephalus
- Molecular Biology Techniques and Applications
Which keywords describe Sean Lilienfeld's research?
The keywords of their largest research topics: Alzheimer's Disease, Neurodegenerative Diseases, Alkaloids, Amaryllidaceae, Oxidative Stress, Acetylcholinesterase, Cholinesterase Inhibitors and Dementia.
- Quantitative
- Cerebrospinal Fluid
- Cerebral Hypoperfusion
- Cerebrolysin
- Crystal Structure
- Dementia
- Acetylcholinesterase
- Amaryllidaceae
- Neurodegenerative Diseases
- Alzheimer's Disease
- Alkaloids
- Oxidative Stress
- Cholinesterase Inhibitors
- Mild Cognitive Impairment
- Nicotinic Acetylcholine Receptors
- Citicoline
- Vascular Cognitive Impairment
- Glymphatic System
- Real-Time PCR
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Alzheimer's Disease344 topics
- Neurodegenerative Diseases142 topics
- Alkaloids111 topic
- Amaryllidaceae111 topic
- Oxidative Stress112 topics
- Acetylcholinesterase101 topic
- Cholinesterase Inhibitors101 topic
- Dementia91 topic
- Mild Cognitive Impairment91 topic
- Crystal Structure81 topic
- Nicotinic Acetylcholine Receptors81 topic
- Cerebrolysin71 topic
- Citicoline71 topic
- Cerebral Hypoperfusion41 topic
- Vascular Cognitive Impairment41 topic
- Cerebrospinal Fluid31 topic
- Glymphatic System31 topic
- Quantitative21 topic
- Real-Time PCR21 topic
Where does Sean Lilienfeld work?
Sean Lilienfeld's main affiliation in the publication record is Janssen (United States), United States.
How many publications and citations does Sean Lilienfeld have?
OpenAlex counts 36 works and 3,583 citations for Sean Lilienfeld, an h-index of 15, ranking #2,017,089 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sean Lilienfeld. Posts are plain text and can be reported.